	S. Korea seeks to become one of 5 global leaders in biotechnologies by 2027 - MSN
	George W. Bush drops by BIO, and so does the FDA commissioner
	European biotech ecosystem takes aim at changing the funding narrative - MSN
	The evolving joint venture landscape in title and real estate
	Tolerance Bio, Inc. Launches With $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases - Business Wire
	Biotech startup targets DiGeorge syndrome with cell therapy
	Syntis Bio Closes $38 Million Financing to Accelerate Oral Therapies for Obesity and Rare Diseases
	Angelini Ventures Invests into $39 Million Series A Extension Round for Therini Bio, a Clinical Stage Company Developing Fibrin-targeting Immunotherapies for ... - Morningstar